Litcius/Paper detail

Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer

Mark M. Awad, Ramaswamy Govindan, Kristen N. Balogh, David R. Spigel, Edward B. Garon, Meghan E. Bushway, Asaf Poran, Joong Hyuk Sheen, Victoria Kohler, Ekaterina Esaulova, John Srouji, Suchitra Ramesh, Rohit Vyasamneni, Binisha Karki, Tracey Sciuto, Himanshu Sethi, Jesse Z. Dong, Melissa A. Moles, Kelledy Manson, Michael S. Rooney, Zakaria Khondker, Mark DeMario, Richard B. Gaynor, Lakshmi Srinivasan

2022Cancer Cell223 citationsDOI

Topics & Concepts

MedicineImmunologyImmune systemPembrolizumabCytotoxic T cellPemetrexedLung cancerCancer researchCD8ImmunotherapyOncologyChemotherapyInternal medicineBiologyCisplatinIn vitroBiochemistryImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkersvaccines and immunoinformatics approaches
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer | Litcius